About Module Innovations
Module Innovations is a company based in Pune (India) founded in 2014. Module Innovations has raised $799.89 thousand across 6 funding rounds from investors including CARB-X, NSTEDB and Department of Biotechnology. Module Innovations offers products and services including USENSe and ASTSENSe. Module Innovations operates in a competitive market with competitors including Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and DxGen, among others.
- Headquarter Pune, India
- SectorsHealthcare
- Website moduleinnovations.com
- Social LinkedIn
- Legal Name Module Innovations Private Limited
- Date of Incorporation 03 Jun, 2014
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹82.7 Lakh
FY 2025 · +446% YoY
- Net Loss-₹29 Lakh
FY 2025 · -35% margin
- EBITDA-₹27.7 Lakh
FY 2025 · -34% margin
- Total Equity Funding$799.89K (USD)
in 6 rounds
- Latest Funding Round$24.17K (USD), Series A
Jan 2024
- InvestorsCARB-X
& 8 more
Associated legal entities of Module Innovations
Module Innovations operates through Module Innovations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Module Innovations Private Limited CIN U74900PN2014PTC151351 | Active | 03 Jun 2014 | Pune, Maharashtra | ₹0.8 Cr | – | 2 | View details |
Products & Services of Module Innovations
Module Innovations offers a comprehensive portfolio of products and services, including USENSe and ASTSENSe.
Rapid test providing UTI positive or negative results in 15 minutes.
Delivers antimicrobial susceptibility profiles in as short as two hours.
Funding Insights of Module Innovations
Module Innovations has successfully raised a total of $799.89K across 6 strategic funding rounds. The most recent funding activity was a Series A round of $24.17 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $799,890
- Total Rounds 6
- Last Round Series A — $24,167
- Investors Count 9
All 6 funding rounds of Module Innovations with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $24,167 | Series A | – | BITS Pilani | – |
| Jun 2020 | $702,000 | Series A | – | CARB-X | – |
| Nov 2016 | $73,723 | Seed | $737,892 | EDC, Entrepreneurship Development Center | – |
| Nov 2016 | $90,000 | Grant | – | – | |
| May 2016 | $15,000 | Grant | – | – | |
| Dec 2014 | – | Grant | – | – |
Last known valuation $737,892 (Nov 2016). 9 investors in total: 9 institutional.
Investors in Module Innovations
Module Innovations has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include CARB-X, NSTEDB and Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in applied generative AI | – | capria.vc | Seattle, United States | |
Antibiotics, vaccines, and diagnostics against drug-resistant bacteria are developed. | 2016 | carb-x.org | Boston, United States | |
Business growth support is provided by EDC in Iowa. | – | edcinc.org | Cedar Rapids, United States | |
- | – | entrepreneurshipdevelopmentcenter.tcc.mode | - | |
Innovation and startup support programs are provided in India. | 1982 | nstedb.com | Delhi, India | |
Startup incubator | – | ciie.co | Ahmedabad, India | |
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
Business incubation services are provided across multiple sectors. | – | birac.nic.in | Delhi, India | |
BITS BioCyTiH Foundation is focused on Bio-CPS technology development. | – | biocytih.co.in | Pilani, India |
Investor details for Module Innovations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Module Innovations Private Limited (Module Innovations)
Module Innovations Private Limited is the primary company behind Module Innovations. The board of Module Innovations Private Limited currently have 2 directors; the longest-serving is Sachin Dubey, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sachin Dubey DIN 06821520 | Director | 03 Jun 2014 | 12 yrs 4 mo | Module Innovations Private Limited |
| Maya Kalaripparambil Viswanathan DIN 09802391 | Director | 29 Nov 2022 | 3 yrs 10 mo | Module Innovations Private Limited |
People of Module Innovations
3 people are tracked at Module Innovations (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Sachhin Dubey | CEO | Leadership |
| Director | Leadership | |
Yaswanth Kumar Rayapati | Research Strategy | Team |
Complete people profiles for Module Innovations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Module Innovations
Figures of Module Innovations Private Limited, the primary company behind Module Innovations, for FY 2025. Revenue was ₹82.7 Lakh (+446% year on year). Net loss was -₹29 Lakh (-35% margin). EBITDA was -₹27.7 Lakh (-34% margin). Revenue has grown at a compounded annual rate of -30% over three years and -6% over five years.
- ₹82.7 LakhRevenue · FY 2025 · +446% YoY
- -₹29 LakhNet loss · -35% margin
- -₹27.7 LakhEBITDA · -34% margin
- ₹1.2 LakhPaid-up capital
- -30%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Module Innovations Private Limited are on its company page.
Detailed financial statements for Module Innovations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Module Innovations
3 dated milestones of Module Innovations across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Module Innovations is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $24K.
Competitors of Module Innovations
Module Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and DxGen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accessbio.net | 2001 | Somerset, United States | $22M | 52 | In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| lumosdiagnostics.com | 2017 | Carlsbad, United States | $40M | – | Diversified diagnostic assays and readers are developed for point-of-care use. | |
| fluxergy.com | 2011 | Irvine, United States | – | 74 | Provides diagnostic devices and software for clinical and veterinary point-of-care testing. | |
| dxgenco.com | 2016 | – | – | – | Point-of-care diagnostic products for diabetes and tuberculosis are provided. | |
| shanxmedtech.com | 2019 | Eindhoven, Netherlands | – | – | In vitro diagnostic platforms for antibiotic testing are provided. | |
| alantissciencesindia.com | 2020 | Manipal, India | – | – | Molecular biology and microbiology research services are provided for diagnostics. | |
| diasurebio.com | 2022 | Seoul, South Korea | $71,475 | – | Rapid antigen tests for infectious diseases are developed. | |
| novo-dx.com | 2022 | Boca Raton, United States | $1.2M | – | Point-of-care diagnostic tests are developed for in-home and clinical use. |
Detailed competitors of Module Innovations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Module Innovations
Complete news archive for Module Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Module Innovations
10 companies that operate in the same segment as Module Innovations (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Module Innovations
Module Innovations was founded in 2014.
Module Innovations is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Module Innovations is a funded company, having raised a total of $799.89K across 6 funding rounds to date.
The primary company behind Module Innovations, Module Innovations Private Limited, reported revenue of ₹82.7 Lakh for FY 2025, up 446% year on year.
Module Innovations was founded in 2014 in Pune, India, within the biotechnology sector. Diagnostic strips are produced by the company to identify bacterial infections through a color shift from blue to red. One-time and reusable nanofiber variants are also created for selective detection of Enterohaemorrhagic Escherichia coli. Operations center on medical diagnostics tools, supporting infection identification in clinical and research settings.
Module Innovations's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
Module Innovations offers USENSe and ASTSENSe.
Module Innovations has 9 investors. Key investors include CARB-X, NSTEDB, Department of Biotechnology, EDC, and Entrepreneurship Development Center.
The valuation of Module Innovations is $737.89K as of Nov 2016.
Module Innovations operates through Module Innovations Private Limited.
The legal entities of Module Innovations currently have 2 directors, including Maya Kalaripparambil Viswanathan, Sachin Dubey.